AbstractÐNovel coumarinic derivatives were synthesized and tested for their inhibitory potency toward a-CT and HLE. Cycloalkyl esters and amides were found to be essentially inactive on both enzymes. On the opposite, aromatic esters strongly inactivated a-CT whereas HLE was less eciently inhibited with dichlorophenyl ester derivatives (k inact /K I =4000 M À1 s À1 for 36). Representative examples of amide, ester, thioester and ketone derivatives were prepared in order to evaluate the in¯uence of the link between the coumarinic ring and the phenyl side chain. The irreversible inactivation of a-CT by 6-chloromethyl derivatives should be due to alkylation of a histidine residue as suggested by the amino acid analysis of the modi®ed chymotrypsin. Conversely the inhibition of HLE was transient. Intrinsic reactivity of coumarins has been calculated using a model of a nucleophilic reaction between the ligand and the couple methanol±water. From this calculation, it appears that dierences in the inhibitory potency expressed by these molecules cannot only be explained by dierences in the reactivity of the lactonic carbonyl group toward the nucleophilic attack. #
Introduction
Serine proteases are attractive targets for the design of enzyme inhibitors since they are involved in the etiology of several diseases. 1À3 Within the class of serine proteases, bovine a-chymotrypsin (a-CT) constitutes an interesting biological tool for the evaluation of new synthetic inhibitors and may be helpful for the design of new therapeutical tools directed against chymotrypsinlike proteases such as cathepsin G and mast cell chymases. Cathepsin G is implicated in in¯ammation and mast cell chymases in allergic responses and psoriasis. 1 Human leukocyte elastase (HLE) is potentially one of the most harmful enzymes in the body. HLE hydrolyzes a wide variety of proteins, including the structural ®bronectin, collagen and elastin. 2 Under physiological conditions, the destructive eects of HLE are limited to the microenvironment immediately surrounding the neutrophils by endogenous proteinase inhibitors (a-1-proteinase inhibitor, secretory-leukoproteinase inhibitor, ela®n). The imbalance between proteases and antiproteases leads to uncontrolled tissue destruction by HLE, which is implicated in the promotion or the exacerbation of a number of diseases including acute respiratory distress syndrome, rheumatoid arthritis, atherosclerosis, pulmonary emphysema and cystic ®brosis. 4À8 A number of low molecular weight inhibitors of chymotrypsin and elastase-like proteinases have been reported as mechanism-based inhibitors. These include halo enol lactones, 9À11 b-lactams, 12À16 saccharin derivatives, 17, 18 benzoxazinones, 19, 20 substituted isocoumarins, 21À23 halomethyldihydrocoumarins 24, 25 and thiadiazolidinones. 26, 27 We previously described the development of coumarinic derivatives 28 characterized by an alkyl, aryl ester (1) or amide (2) function in the position 3 ( Fig. 1) . The electrophilic chloromethyl moiety in the position 6 was required to irreversibly inhibit a-CT. This is consistent with a mechanism in which the lactone group undergoes the nucleophilic attack of the active serine residue (Fig.  2) . After the ring opening, the elimination of HX from the benzylic derivative is a fast reaction in mild conditions when X is a good leaving group such as a chlorine. 29 The resulting electrophilic quinone methide could form a covalent bond with a nucleophilic residue such as His-57 or Met-192 located within the enzyme recognition site. Structure±activity relationships established that the nature of the substituent in position 3 strongly in¯uences the inhibitory potency on the serine protease.
According to these considerations, we modulated the coumarinic template in order to improve the inhibitory potency. In the present work, we report the synthesis and the inhibition studies of new cycloalkyl or aryl esters and amides of 6-chloromethyl-2-oxo-2H-1-benzopyran-3-carboxylic acid. The nature of the substitution on the phenyl side chain was also studied as well as its link to the coumarinic ring. Finally, the interest of the 6-chloromethyl moiety was further investigated. Intrinsic reactivity has been calculated using a model of a nucleophilic reaction between the ligand and the couple methanol±water. 30 The postulated mechanism involves an alkylation within the active site; we performed an amino acid analysis of the modi®ed a-CT in order to determine which amino acid residue was alkylated.
Chemistry
Generally, the acyl chloride of 6-chloromethyl-2-oxo-2H-1-benzopyran-3-carboxylic acid 6 was obtained by treatment of the starting compound 5 with thionyl chloride (Scheme 1). This intermediate 6 was then converted into esters (11±15, 26±37), amides (16±25, 38, 40) or thioesters (39, 41) by reaction with the appropriate alcohol, amine or thiol, respectively.
Compound 10 (Scheme 2) was prepared from 5-(hydroxymethyl)salicylaldehyde (7), which reacted with ethyl benzoylacetate (8) in a Knoevenagel-type reaction leading to 3-benzoyl-6-(hydroxymethyl)-2H-1-benzopyren-2-one (9) . Treatment of 9 with thionyl chloride led to 3-benzoyl-6-(chloromethyl)-2H-1-benzopyren-2-one (10).
Products 42±47 were prepared from the appropriate carboxylic acid by treatment with thionyl chloride and then with phenol, or 3-chlorophenol, respectively (Scheme 3).
Results and Discussion
The newly synthesized compounds were examined on a-CT and HLE either by the preincubation method or by the progress curve method (Tables 1±4) . These coumarin derivatives were expected to act as irreversible inhibitors of a-CT.
In the cycloalkyl ester series, only 11 and 14 (k inact /K I 470 and 3300 M À1 s À1 , respectively) weakly inhibited a-CT (Table 1 ). The cycloalkyl amide derivatives (16±25) failed to inhibit a-CT and HLE. These results con®rm the in¯uence on the inactivation process of the nature of the substituent at the C-3 position; the presence of an aromatic moiety strongly improves the inhibition. 28 Consequently, we focused our works on aryl ester derivatives by analyzing the eect on inhibition of substituent on the aromatic moiety. The compounds 26±34 and 36 behaved as time-dependent inhibitors of a-CT and HLE, whereas 35 was found to be inactive (Table  2) . A strong inactivation was observed with derivatives bearing a single halide or a methoxy group located in the meta position (28±31). The presence of a second substituent on the phenyl ring did not improve the inhibitory activity toward a-CT (32±36). However, the inhibitory potency toward HLE was increased with the dichlorophenyl ester derivatives 34 and 36. Since no spontaneous and hydroxylamine-mediated reactivations of the enzyme were observed, the a-CT inhibition encountered with these coumarinic derivatives was considered to be irreversible. This phenomenon can be explained by a second hit mechanism (Fig. 2) . After the nucleophilic attack of the lactonic carbonyl ring and the formation of the acyl enzyme, alkylation of the active site His-57 residue could occur as a consequence of the quinone methide formation resulting from the halogen ion elimination. On the opposite, the inhibition of HLE by coumarin derivatives is transient as evidenced by the slow and complete reactivation within 20 h of the enzyme treated with compound 36. This reactivation of the enzyme, speeded up by treatment with hydroxylamine, supports, therefore, the formation of a stable acyl-enzyme, suggesting that these inhibitors act as alternate substrates of HLE. Consequently, the values of k obs /[I] reported in Tables 1±4 correspond to the acylation step.
In order to evaluate the importance of the link between the coumarinic ring and the phenyl residue, we prepared representative examples of amide, ester, thioester and ketone compounds which were tested for their inhibitory potency toward a-CT and HLE ( Fig. 3A and Tables 1±3). As compared to their ester counterparts, the two derivatives with an amide link were found to be inactive (37 versus 38 and 31 versus 40). The absence of any inhibitory potency expressed by these amide derivatives could be related to the formation of a strong intramolecular hydrogen bond between the oxygen atom of the lactonic carbonyl and the proton of the amide nitrogen atom. As developed further, this hydrogen bond induces a more restricted conformational mobility of the amide side chain. Interestingly, the inactivation potency of the m-chlorophenyl thioester derivative toward a-CT was in the same range as that of the corresponding ester (31 versus 41). Replacement of the ester function by a ketone group led to an important decrease of the inhibitory potency (37 versus 10).
However, it was interesting to note that 10 is still an inactivator, in agreement with a reaction of the active serine with the carbonyl group of the lactone. The partition ratio r which represents the average number of enzyme`turnovers per inactivation' (k c /k inact ) was determined for the inhibition of a-CT by some of the most powerful inactivators 31, 34, 36 and 41 and was found equal to 1.8, 2.4, 6.3 and 1.05, respectively (Fig.  3B) . As a result, the partition ratio of thioester 41 is close to that of an optimal inhibitor (an ideal suicide substrate would display an r value equal to 0). Phenyl 6-methyl-2-oxo-2H-1-benzopyran-3-carboxylate (42), the non-halogenated analogue of 37, was found to be inactive on a-CT, indicating that the halomethyl moiety is required to obtain an irreversible inactivation of a-CT (Table 4 ). In order to con®rm this result, we prepared esters 43±47 of 2-oxo-2H-1-benzopyran-3-carboxylic acid substituted in the position 6 with a group devoid of a latent alkylating function or bearing a potentially poor leaving group (acetate) ( Table 4) . Compounds 42 and 43 did not inactivate a-CT and behaved as substrates (
). This could be explained by the formation of a stable acyl-enzyme (no possibility to unmask an alkylating function). The substitution at the meta position by a chlorine atom strongly in¯uenced the interaction of coumarins with a-CT (45/42, 46/43, 47/ 44). The inactivation of a-CT by 47 was found to be irreversible with a poor partition ratio (r=80). The corresponding 6-chloromethyl analogue 31 led to a smaller value of r (r=1.8). This may be due to a less nucleofugal leaving group [pK a (acetate)=4.76 and pK a (Cl)=À6.1]. With other series of suicide substrates, it has been reported that acetate, as a leaving group, does not lead to irreversible inhibition. 16,31À33 In the a-CT recognition site, two amino acids may be alkylated: No inactivation at 10 mM. catalytic His-57 or Met-192, which caps the primary speci®city pocket. The amino acid analysis of native enzyme and enzyme modi®ed by 31 and 34 showed a decrease of the histidine content from 2 residues to 1 with no change in the methionine content. This demonstrates that a histidine residue has been modi®ed and that the inactivation of a-CT may be due to the modi®cation of His-57. Interestingly, the 3-chlorophenyl esters 45±47 were found to inhibit HLE with an eciency equal or superior to that of the 6-chloromethylsubstituted analogue 31. This indicated that the presence of an alkylating group was not required for the inhibition of HLE. This result might be explained by an alternative mode of action. An adequate proximity between the alkylating moiety of the drug and the catalytic histidine should not be realized in the active site of HLE. It should also be speculated that HLE attacks at the exocyclic ester group instead of the lactone. 34 Optimized geometries of the ligand After optimization, 37 revealed two minimal energetic geometries with respect to the dihedral angle C 2 -C 3 -C 14 -X 16 value (Table 5 ). These minima correspond to two conformations (a and b) characterized by an opposite value for this dihedral angle. The most stable b-conformation of 37 is close to that observed in the X-ray structure of 30, where both carbonyl groups point in the same direction (Fig. 4) . The energetic level of the transition state structure (TS) between the two conformers is only 3.3 kcal/mol and it can be assumed that equilibrium between both of them could exist. The same feature occurs for the thioester 39. On the contrary, the amide function in 38 highly stabilizes the conformer a by an internal H-bond (C 2 O ...... HN 16 , Table 5 and Fig.  5) . A ®rst TS is located before the minimum b 1 which itself is separated from a symmetrical other one by a second TS located at 11 kcal/mol from the ®rst minimum. Thus, it clearly appears that the side chain in the position 3 of the amide 38 exhibits a lower conformational freedom than that calculated for the corresponding ester 37 and the thioester 39.
Nucleophilic model of the intrinsic reactivity
Ab initio calculation led us to determine the energetic barrier (ÁE) required to reach the transition state structure in an interaction model involving the ligand and the couple methanol±water used as nucleophile ( Fig. 6 and Table 6 ). As an example, the two minimum conformations of the amide 38 and their respective geometry at the transition state are given in Figure 7 . This approach has been successfully applied in the study of the acylation mechanism of a-chymotrypsin. 30 The activation barrier for the lactone ring 48 comprising two conjugated double bonds is signi®cantly higher than that calculated for methyl formate taken as reference. By introducing a phenoxycarbonyl moiety in the position 3 of the lactone ring 49, the ÁE value is lowered and re¯ects a higher intrinsic reactivity of the lactonic carbonyl function. This could be explained by the electron withdrawing eect of the phenoxycarbonyl group. Adjunction of a benzene ring to the lactone 48 leading to coumarin 50 slightly increases the reactivity. The intrinsic reactivity of the 6-chloromethyl-substituted coumarinic compound 51 is also improved when compared to the lactone ring alone (48) or the coumarin 50. Association of the coumarinic structure with a phenoxycarbonyl moiety in the position 3 (52) leads to a theoretical intrinsic reactivity slightly lower than that of 37, which includes a chloromethyl substituent. Thus, a coumarinic compound bearing a 3-phenoxycarbonyl and/or a 6-chloromethyl group may have a higher reactivity compared to the simple coumarinic derivative 50, devoid of both substituents. These results also con®rm that the coumarinic core structure like 37 should have the appropriate reactivity for interacting with serine enzymes. Further calculations have been made in order to appreciate the in¯uence of the position of the chlorine atom on the phenyl ring. As observed in Figure 6 , only slight dierences are noted between compounds 53, 31 and 54. Their ÁE is similar or lower to that of 37, devoid of this halogen atom. Indeed, a slight increase of the intrinsic reactivity is only noted for 53, the ortho chloride derivative. By comparison with compound 53, the energy barrier of the 2,6-dichloro substituted derivative 35 is slightly increased and that of compound 33 is decreased. Even though the intrinsic reactivity of all the mono-and di-chloro derivatives remains in the the same energetic range, the inhibitory potency greatly diers. For example, the 2,6-dichloro substituted derivative 35 is inactive against a-CT whereas the 2,5-dichloro 34 is very potent (Table 2) . Consequently, differences in the inhibitory activity expressed by these chlorophenyl or dichlorophenyl molecules (Table 2 and  ref 35 ) cannot be only explained by dierences in the reactivity of the lactonic carbonyl group involved in the nucleophilic attack. The most important geometric feature which could explain the marked variations in the kinetic parameters toward a-CT is probably related to the preferential conformation adopted by the substituted phenoxycarbonyl side chain. Finally, the examination of the antiparallel a conformer and parallel b conformer of 38 led to the conclusion that the conformation 38a gave a signi®cantly higher reactivity of the lactonic carbonyl compared to the conformation 38b (Table 6 and Fig. 7 ). This phenomenon is directly related to the stabilization of the partially negatively charged O carbonyl by the neighboring H±N amide group (Fig. 7) . However, even if the theoretical reactivity of the amide 38a was higher than the corresponding ester 37, the lack of inhibitory activity of 38 should be explained by the restricted conformational freedom of the amide, which should be responsible for a lowering of the recognition adaptability during receptor site interaction. Regarding compounds 37 and 39, no dierences are noted for the activation energy of a and b (Table 6 ). 
Conclusion
The ester and thioester coumarinic derivatives possess the structural requirements to act as ecient inactivators of serine proteases. The lack of inhibitory activity of the amide derivatives should be explained by a poor recognition of the molecule by the enzyme rather than by a lack of reactivity toward nucleophilic addition. The determination of intrinsic reactivity of the lactone indicates that the potency of the phenyl derivatives is rather due to the conformation of the phenoxycarbonyl side chain than the intrinsic reactivity of the lactone. In order to support this theoretical approach, the kinetic parameters of alkaline hydrolysis of these coumarins could be helpful. 36, 37 The irreversible inactivation of a-CT by these compounds probably implies an alkylation of a histidine residue in the receptor site. On the contrary, the inactivation of HLE was transient and the enzyme slowly recovered its activity. The modulation of substituents in the position 3 and in the position 6 opens the way for the design of selective inhibitors of HLE. 
3-Benzoyl-6-(hydroxymethyl)-2H-1-benzopyren-2-one (9).
A mixture of 5-(hydroxymethyl)salicylaldehyde (7) (0.76 g, 5 mmol), ethyl benzoylacetate (8, 1.056 g, 5.5 mmol), piperidine (0.1 mL) and ethanol (5 mL) was re¯uxed for 10 min. After cooling, the precipitate was collected and washed with ethanol to give the title compound (0.63 g, 45%): mp 170±172 
3-Benzoyl-6-(chloromethyl)-2H-1-benzopyren-2-one (10).
3-Benzoyl-6-(hydroxymethyl)-2H-1-benzopyren-2-one (9) (1 g; 3.57 mmol) was heated in thionyl chloride (10 mL) for 3 h. The resulting solution was concentrated under reduced pressure and the residue was dispersed in dry toluene (10 mL General procedure for the preparation of the esters (11±15, 31, 37), thioesters (39, 41) and amides (16±25, 38, 40) of 6-chloromethyl-2-oxo-2H-1-benzopyran-3-carboxylic acid, of the esters of 2-oxo-2H-1-benzopyran-3-carboxylic acid (43, 46) and of the esters of 6-acetoxymethyl-(44, 47) and 6-methyl-2-oxo-2H-1-benzopyran-3-carboxylic acids (42, 45) The appropriate coumarinic acid (1 g) was suspended in thionyl chloride (10 mL) for 3 h. The resulting solution was evaporated to dryness under reduced pressure and the residue was dispersed in dry toluene (10 mL). The solvent was eliminated under reduced pressure. Dispersion in dry toluene and solvent elimination was repeated twice. The residue reacted with the appropriate alcohol (1.1 equiv), amine (1.1 equiv) or thiol (1.1 equiv) in the presence of anhydrous pyridine as previously described. Cycloheptyl 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylate (12 1H, 7-H), 8.35 (s, 1H, 4-H 1-Methylpiperid-3-yl 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylate (15 
N,N
H -Dipropyl-6-(chloromethyl)±2-oxo-2H-1-benzopyran-3-carboxamide (23 
39
Hydroxylamine reactivation assays were performed by treating inactivated a-CT solutions with 0.5 M hydroxylamine at pH 7.5 and 25 C during 30 min. Enzyme activity of aliquots was monitored and compared to a control.
In order to perform the amino acid analysis of native and inactivated a-CT by 31 and 34, the enzyme samples were dried under vacuo and hydrolyzed by 6 N HCl at 105 C during 23 h. The amino acid mixtures were then modi®ed using phenylisothiocyanate (PITC), analyzed by HPLC on a PICO-TAG column (3.9Â150 mm, WATERS) and compared to a sample of a standard amino acid mixture treated according to the same procedure. The determination of the amino acid composition was based on the presence of 4 tyrosine residues.
X-Ray crystallography
Crystals of 30, C 17 H 10 O 4 BrCl, M r =393.6, were obtained by slow evaporation of a concentrated solution in CH 3 CN. A crystal measuring 0.47Â0.28Â 0.025 mm was selected for the crystallographic study: monoclinic, P2 1 , a=6.248(1) A Ê , b=7.618(1) A Ê , c= 15.975(2) A Ê , b=94.87 (1) , V=757.6(2) A Ê , 3 Z=2, "= 5.488 mm À1 , D x =1.725 g cm À3 , l(CuK a )=1.54178 A Ê , F(000)=392, T=290 K, 1893 unique re¯ections (R int =0.015), R 1 =0.0338 for 1798 F o >4s(F o ) and wR 2 =0.0947, GOF=S=1.028. Absorption eects were corrected using analytical methods, T max =0.763 and T min =0.245. Full matrix least-squares on F 2 .
Calculation
All the calculations have been performed at the ab initio RHF level using the minimal basis set MINI-1 H . 40, 41 They were performed with Gaussian 94 42 on two computers, a Dec Alpha 8400 8-processor and a Dec Alpha 4100 4-processor running Digital Unix. The starting geometries were sketched drawn by standard fragments and then completely optimized following all the 3NÀ6 degrees of freedom either for the minima or the transition state structures. For each equilibrium structure, the thermochemistry data are derived from the analytical frequency calculation at 298.15 K and 1 atm. The conformational analysis of 37, 38 and 39 has been performed following the rotatable bond of the carbonyl moiety of the substituent using a stepsize of 30 degrees. At each point, the 3NÀ5 degrees of freedom have been reoptimized allowing us to locate the positions of the extrema, i.e., the minima and the transition state structure(s) between them.
Supporting information available X-Ray crystallographic data, including positional parameters, bond distances, bond angles, torsion angles, and anisotropic displacement parameter expressions for 30 and all the equilibrium structure geometries as well as frequency calculation and/or Z-matrices are available on request from the authors.
